Workshop: Microbiological control in tissue establishments September 14, 2017

Appropriate testing for the presence and growth of microorganisms, training of personnel handling aseptic operating conditions during sampling and selecting the right samples for testing are just some of the factors associated with the management of microbiological control during the manufacturing of tissue and cell grafts.

This interactive workshop encompasses everything tissue bank ope...

Guide to the preparation, use and quality assurance of blood components

The 19th edition of the Guide to the preparation, use and quality assurance of blood components is now available and may be downloaded free of charge.

https://register.edqm.eu/freepubRea...

Single European Code (SEC)

Member States were required to transpose the provisions of Directive (EU) 2015/565 into their national legislation by 29 October 2016. Pending the transposition of EU directive 2015/565 into Belgian legislation the FAMHP published an information note in order to allow the tissue establishment to start the necessary measures. The information note does not indicate an implementation date.

...

Spring symposium – Quality indicators in tissue establishments

It is our pleasure to invite you to the Spring Symposium of the BVWB-ABBT which will be held on May, 18th, 2017 at the Bordet Institute at Brussels. 

See flyer for more information about the program and the speakers. Feel free to share t...

European tissue establishment compendium

The European tissue establishment (TE) compendium carries information on all  authorized, licensed, designated or accredited TEs in the EU including the TEs located in Belgium. The compendium includes the category of tissues/cells and the type of activities carried out in the TE...

Hospital exemption ATMP

The slides of the information session are now available on the member MENU under the section FAMHP.

Recently the royal decree concerning the hospital exemption for the production of advanced therapy medicinal products is published (March 1, 2017). The Federal Agency for Medicines and Health Products organized an information session on April 24, 201...